Diabetes protects from prostate cancer by downregulating androgen receptor: new insights from LNCaP cells and PAC120 mouse model.
Barbosa-Desongles, Anna; Hernández, Cristina; De Torres, Ines; Munell, Francina; Poupon, Marie-France; Simó, Rafael; Selva, David M.
; 8(9): e74179, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24058525
Elevation of SHARPIN Protein Levels in Prostate Adenocarcinomas Promotes Metastasis and Impairs Patient Survivals.
Reduced expression of the DNA glycosylase gene MUTYH is associated with an increased number of somatic mutations via a reduction in the DNA repair capacity in prostate adenocarcinoma.
Role of the TNF-α receptor type 1 on prostate carcinogenesis in knockout mice.
TGF-ß Tumor Suppression through a Lethal EMT.
Conceptual and Experimental Tools to Understand Spatial Effects and Transport Phenomena in Nonlinear Biochemical Networks Illustrated with Patchy Switching.
Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis.
Human endogenous retrovirus HERV-K(HML-2) activity in prostate cancer is dominated by a few loci.
Punctuated evolution of prostate cancer genomes.
ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients.
Myc Cooperates with Ras by Programming Inflammation and Immune Suppression.